Keenan Greg — SEC Form 4 filings

SEC reporting owner CIK 2044006. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-10.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2025-03-04 to 2026-03-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aurinia Pharmaceuticals Inc. (AUPH)SVP, Chief Medical Officer63 legs · 40,544 sh · $376,2626

Form 4 filings — Keenan Greg

FiledFormIssuerReported transactionsSource
2026-03-104Aurinia Pharmaceuticals Inc. (AUPH)Tax withholding (F): 8,069 @ $14.32EDGAR
2026-03-034Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 40,586 @ $0 · Grant/award (A): 67,870 (derivative) @ $0EDGAR
2026-02-034Aurinia Pharmaceuticals Inc. (AUPH)Tax withholding (F): 11,552 @ $14.53EDGAR
2025-08-054Aurinia Pharmaceuticals Inc. (AUPH)Sale (S): 20,000 @ $10.50EDGAR
2025-03-074Aurinia Pharmaceuticals Inc. (AUPH)Sale (S): 8,305 @ $8.23EDGAR
2025-03-044Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 62,583 @ $0 · Sale (S): 12,239 @ $8 · Grant/award (A): 95,570 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2044006 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →